A Study of the Safety and Immunogenicity of Repeated rhC1INH Administration

Clinical trial NCT00851409 · COMPLETED

Trial details

NCT number: NCT00851409
Sponsor: Pharming Technologies B.V.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Genetic Disorders Hereditary Angioedema

Start date: 2009-06-01
Primary completion: 2010-03-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.